Clinical Trial: Observational Study on Endometrial Stromal Tumors

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Endometrial Stromal Tumors: an Observational Study

Brief Summary: Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

Detailed Summary:

Observational, retrospective and prospective study on EST aimed to understand more about its biology, natural history and antitumor activity of different treatment options.

This study will collect data in prospective and retrospective way of patients affected by EST and treated according disease guidelines and local practices.

The study will also review the diagnosis by a central expert pathologist in order to its confirmation


Sponsor: Italian Sarcoma Group

Current Primary Outcome: Disease natural history [ Time Frame: Through survival, an average of 5 years ]

Collection of data on the natural history of endometrial stromal tumors


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Disease diagnosis and classification [ Time Frame: At the time of diagnosis, an average of 1 month ]
    Highlight some main issues in pathologic diagnosis of these tumors and their classification
  • Chemotherapy received treatment [ Time Frame: Through treatment completion, an average of 24 month ]
    Number and type of chemotherapy agents received for EST treatment


Original Secondary Outcome: Same as current

Information By: Italian Sarcoma Group

Dates:
Date Received: July 8, 2016
Date Started: October 2016
Date Completion: August 2022
Last Updated: January 9, 2017
Last Verified: January 2017